Bdbusinessdaily.com – A medication mix-up at a private hospital in Chattogram left a newborn in the neonatal intensive care unit after staff allegedly administered an injection meant for his mother directly into the infant. The episode, which unfolded on 5 September at the Center for Specialized Care and Research (CSCR), has drawn scrutiny over how bedside verification protocols function in postpartum wards and whether a single nurse’s lapse can be treated as the full explanation for what happened.

The drug in question, Rhophylac 300 (Human anti-D [Rh] immunoglobulin), is a standard prophylactic given to mothers whose blood type is Rh-negative when they deliver a baby with an Rh-positive blood group. Without the shot, maternal antibodies can form and attack red blood cells in subsequent pregnancies, a condition known as Rh isoimmunisation. In this case, 34-year-old Shakila Yasmin was found to carry A-negative blood while her newborn carried A-positive blood, making…